Albireo Pharma, Inc. (ALBO): Price and Financial Metrics
Albireo Pharma, Inc. (ALBO)
Today's Latest Price: $37.65 USD
0.10 (-0.26%)
Updated Dec 2 4:00pm
Add ALBO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ALBO Stock Summary
- With a price/sales ratio of 59.9, Albireo Pharma Inc has a higher such ratio than 95.93% of stocks in our set.
- As for revenue growth, note that ALBO's revenue has grown 218.41% over the past 12 months; that beats the revenue growth of 97.09% of US companies in our set.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for ALBO comes in at -28.65% -- higher than that of only 11.39% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to Albireo Pharma Inc, a group of peers worth examining would be ARDX, ALPN, CLLS, BBIO, and BLCM.
- ALBO's SEC filings can be seen here. And to visit Albireo Pharma Inc's official web site, go to www.albireopharma.com.
ALBO Stock Price Chart Interactive Chart >
ALBO Price/Volume Stats
| Current price | $37.65 | 52-week high | $49.00 |
| Prev. close | $37.75 | 52-week low | $11.26 |
| Day low | $37.35 | Volume | 136,780 |
| Day high | $38.57 | Avg. volume | 193,854 |
| 50-day MA | $34.67 | Dividend yield | N/A |
| 200-day MA | $27.20 | Market Cap | 718.25M |
Albireo Pharma, Inc. (ALBO) Company Bio
Albireo Pharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and gastrointestinal (GI) disorders. The company is based in Boston, Massachusetts.
Loading social stream, please wait...